Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (491)	7/18/2002 6:17:36 PM
From: Jibacoa	Read Replies (1) of 544

TBIO Is among the few Biotechs staying out of the red camp today.<g> It is up 6% after it announced yesterday a deal with GRN to supply modified nucleic acid building block compounds that Geron will use to synthesize GRN163. GRN163 which reportedly works by inhibiting telomerase, has demonstrated to be effective in animal models of glioblastoma, prostate Ca, lymphoma and multiple myeloma. siliconinvestor.com The stock needs to close above 3.75 before it can test the resistance at 5. The long term average line stands at 4.06 siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next